TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: Impaired B cell maturation in mice lacking BLyS

Citation
Ja. Gross et al., TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: Impaired B cell maturation in mice lacking BLyS, IMMUNITY, 15(2), 2001, pp. 289-302
Citations number
49
Categorie Soggetti
Immunology
Journal title
IMMUNITY
ISSN journal
10747613 → ACNP
Volume
15
Issue
2
Year of publication
2001
Pages
289 - 302
Database
ISI
SICI code
1074-7613(200108)15:2<289:TNMCFB>2.0.ZU;2-U
Abstract
BLyS and APRIL have similar but distinct biological roles, mediated through two known TNF receptor family members, TACI and BCMA. We show that mice tr eated with TACI-Ig and TACI-Ig transgenic mice have fewer transitional T2 a nd mature B cells and reduced levels of circulating immunoglobulin. TACI-Ig treatment inhibits both the production of collagen-specific Abs and the pr ogression of disease in a mouse model of rheumatoid arthritis. In BLyS-defi cient mice, B cell development is blocked at the transitional T1 stage such that virtually no mature B cells are present, while B-1 cell numbers are r elatively normal. These findings further elucidate the roles of BLyS and AP RIL in modulating B cell development and suggest that BLyS is required for the development of most but not all mature B cell populations found in the periphery.